Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients

NCT07068074 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT07068074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07068074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Study of Management of Treatment Naive Primary Melanoma in Elderly Patients
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Phase 3
Overall status
Recruiting
Start date
April 17, 2026
Completion date
January 1, 2031
Enrollment
428 (estimated)
Sites
181

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous melanoma